Posted by Susan E. Engel, Matthew Rawlinson, and Peter Trombly, Latham & Watkins LLP, on Wednesday, August 31, 2022 Editor's Note: Susan E. Engel and Matthew Rawlinson are partners and Peter Trombly is an associate at
Orbit Capital, a Czech investment firm, is on the road to raise EUR 200m for its new fund investing in scaleups, general partner Radovan Nesrsta told Unquote.
Oakley Capital has acquired Inflexion-backed Phenna Group and Palatine-owned Construction Testing Solutions (CTS), two UK-based testing, inspecting, certification, and compliance providers (TICC).
Adelis Equity Partners has sold its majority stake in Nordic dental labs group Nordentic to peer Corus, backed by CareVentures and Quadrum Capital.
DW Healthcare Partners has sold veterinary pharma specialist Med-Pharmex to trade buyer Dechra Pharmaceuticals after almost a decade in its portfolio. The post After almost a decade of ownership, DW Healthcare seals Med-Pharmex trade sale
Patient Square Capital founding partner Alex Albert has been named chairperson of the Healthcare Private Equity Association, which represents members with over $4tn of assets under management. The post Patient Square Capital founding partner Alex
Holland Capital has sold Dutch IT services provider Eshgro to Strikwerda Investments, a Netherlands-based family office.
Central Europe-focused private equity house Genesis Capital has teamed with Integral Venture Partners to buy train seats and interior equipment specialist BORCAD. The post Genesis Capital teams with Integral to buy veteran Czech train seat
Capital markets risk management tech business and quantitative research pioneer Numerix has been bought by private equity major Genstar Capital. The post Capital markets risk management tech specialist Numerix bought by Genstar Capital first appeared
Stirling Square Capital Partners has halted the sale of Outcomes First Group, a UK specialist care and fostering provider, after almost nine months of trying to get a deal over the line, two sources familiar
Stafford Capital Partners has hauled in more than €730m for the final close of its fourth flagship infrastructure secondaries fund, alongside another £100m in a separate managed account. The post Infra secondaries’ stable yield helps
Commercial real estate developer Al Neyer has pulled in $200m for the final close of its second fund, double the equity it raised for its debut vehicle last year. The post Al Neyer scores big
InvestBev LLC, the Nation’s largest adult beverage only focused private equity firm has completed a multi-million dollar investment into Cann Social Tonics: America's #1 selling microdosed...(PRWeb August 31, 2022)Read the full story at https://www.prweb.com/releases/2022/8/prweb18862956.htm
DLA Piper has appointed Thomas Priolet to the Paris corporate practice to strengthen the law firm’s international private equity offering alongside two associates.
In a market presenting increasing opportunities for Tyrus Capital’s late-stage and mature secondaries-focused private equity strategy, Unquote speaks to Gunter Waldner, head of private equity, about the firm’s deployment plans and outlook.
Private equity major Thoma Bravo has agreed the $3.725bn sale of admin software business Frontline Education to New York Stock Exchange-listed Roper Technologies. The post Thoma Bravo seals $3.725bn Frontline Education sale to Roper Technologies
Inflexion has scored a strong exit of testing and inspection business Phenna through a £1bn-plus sale to fellow private equity investor Oakley Capital. The post Inflexion’s Phenna valued at over £1bn through sale to Oakley
Align Capital Partners has scored a rapid exit of accounting and tax services business WilliamsMarston after just two years in its portfolio. The post After two years of bolt-ons, Align Capital has sold WilliamsMarston to
Specialist healthcare investor Gilde Healthcare has agred to carve out blood group and immune reagents business Sanquin Reagents from Sanquin Health Solutions. The post First deal from Gilde Healthcare’s €517m Fund IV sees firm carve out
